EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Emodin Exerts Dual Hepatoprotective/Hepatotoxic Effects Dependent on Metabolic Microenvironment via Gut–Liver Axis Crosstalk: A Multi-Omics Study in MAFLD and Normal Mice

Rui Mao, Yuxia Guo, Haiyan Zhang, Ruiqi Wang, Yangang Cheng, Huifeng Li, Yan Wang, Yingli Wang

International Journal of Molecular Sciences · 15.05.2026 · 27 (10) · 4411

DOI: 10.3390/ijms27104411 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.05.2026. Verfasst von Rui Mao und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Tradition Chinese Medicine, Shanxi University of Chinese Medicine, Jinzhong 030619, China. Hauptthemen laut MEDLINE: Emodin, Liver, Gastrointestinal Microbiome, Non-alcoholic Fatty Liver Disease. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanxi Provincial Science and Technology Department, Shanxi Provincial Bureau of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Emodin exhibits promising hepatomodulatory potential, yet its precise actions remain poorly characterized across distinct hepatic pathological states. Dose-dependent effects of emodin (40, 80, and 120 mg/kg) were investigated in mice with metabolic dysfunction-associated steatotic liver disease (MASLD), as well as healthy control mice, through integrated histopathological, biochemical, metabolomic, and gut microbiota profiling. The 80 mg/kg dose tended to yield the most favorable hepatoprotective outcomes in MASLD mice, whereas the 120 mg/kg dose was accompanied by apparent adverse hepatic alterations in normal mice. Correlative analyses further suggested that such divergent hepatic responses may be potentially linked to the gut microbiota–short-chain fatty acid (SCFA) axis, as well as the modulation of BAX/Bcl-2 balance and ESR1 expression. The hepatic effects of emodin are state- and dose-dependent. The dose of 80 mg/kg may represent a plausible candidate therapeutic range for MASLD, and the gut–liver axis is proposed as a likely underlying regulatory pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EmodinLiverGastrointestinal MicrobiomeNon-alcoholic Fatty Liver DiseaseProtective AgentsAnimalsMiceMaleMultiomicsMetabolomics

Stichwörter der Autor:innen

MASLDdose-response relationshipemodingut-liver axishost metabolic microenvironmentmulti-omics integration

Substanzen

EmodinProtective Agents

Autor:innen und Institutionen

  • College of Tradition Chinese Medicine, Shanxi University of Chinese Medicine, Jinzhong 030619, China.

Förderung

  • Shanxi Provincial Science and Technology Department
  • Shanxi Provincial Bureau of Traditional Chinese Medicine

Zitieren

APA

Mao, R., Guo, Y., Zhang, H., Wang, R., Cheng, Y., Li, H., Wang, Y., & Wang, Y. (2026). Emodin Exerts Dual Hepatoprotective/Hepatotoxic Effects Dependent on Metabolic Microenvironment via Gut–Liver Axis Crosstalk: A Multi-Omics Study in MAFLD and Normal Mice. International Journal of Molecular Sciences, 27(10), 4411. https://doi.org/10.3390/ijms27104411

Vancouver

Mao R, Guo Y, Zhang H, Wang R, Cheng Y, Li H, et al. Emodin Exerts Dual Hepatoprotective/Hepatotoxic Effects Dependent on Metabolic Microenvironment via Gut–Liver Axis Crosstalk: A Multi-Omics Study in MAFLD and Normal Mice. International Journal of Molecular Sciences. 2026;27(10):4411. doi:10.3390/ijms27104411

BibTeX
@article{Mao2026,
  author = {Mao, Rui and Guo, Yuxia and Zhang, Haiyan and Wang, Ruiqi and Cheng, Yangang and Li, Huifeng and Wang, Yan and Wang, Yingli},
  title = {Emodin Exerts Dual Hepatoprotective/Hepatotoxic Effects Dependent on Metabolic Microenvironment via Gut–Liver Axis Crosstalk: A Multi-Omics Study in MAFLD and Normal Mice},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {10},
  pages = {4411},
  doi = {10.3390/ijms27104411}
}
Kostenlos starten →